Enanta Pharmaceuticals
ENTA
#8126
Rank
HK$2.85 B
Marketcap
HK$98.09
Share price
3.31%
Change (1 day)
9.99%
Change (1 year)

Market capitalization of Enanta Pharmaceuticals (ENTA)

Market cap: HK$2.85 Billion

As of October 2026 Enanta Pharmaceuticals has a market cap of HK$2.85 Billion. This makes Enanta Pharmaceuticals the world's 8126th most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.

Market cap history of Enanta Pharmaceuticals from 2013 to 2026

End of year Market Cap

Year Marketcap Change
2026HK$2.85 B-24.5%
2025HK$3.78 B282.65%
2024HK$0.98 B-36.1%
2023HK$1.54 B-79.53%
2022HK$7.55 B-36.78%
2021HK$11.95 B82.46%
2020HK$6.55 B-31.25%
2019HK$9.53 B-11.58%
2018HK$10.77 B22.94%
2017HK$8.76 B77.28%
2016HK$4.94 B2.83%
2015HK$4.81 B-34.48%
2014HK$7.34 B93.17%
2013HK$3.80 B

End of Day market cap according to different sources

On Oct 9th, 2026 the market cap of Enanta Pharmaceuticals was reported to be:

HK$2.85 Billion
by Nasdaq info icon info icon
HK$2.85 Billion
by CompaniesMarketCap info icon info icon

Market capitalization for similar companies or competitors

Name Marketcap Market cap differencediff. Country
Johnson & Johnson
JNJ
HK$4.944 T 172,956.86%๐Ÿ‡บ๐Ÿ‡ธ USA
Novartis
NVS
HK$2.144 T 74,948.65%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
AbbVie
ABBV
HK$3.833 T 134,093.49%๐Ÿ‡บ๐Ÿ‡ธ USA
Vertex Pharmaceuticals
VRTX
HK$1.013 T 35,388.82%๐Ÿ‡บ๐Ÿ‡ธ USA
Merck
MRK
HK$2.818 T 98,568.56%๐Ÿ‡บ๐Ÿ‡ธ USA
Bristol-Myers Squibb
BMY
HK$947.66 B 33,071.12%๐Ÿ‡บ๐Ÿ‡ธ USA